Abstract
Human body comprises trillions of microbial cells associated with different parts of the body. The composition of microorganisms is different in all the parts of the body. Skin, oral, respiratory, placental, gut, and vaginal microbiome are well explored and studied for their effect on human health and disease. The largest part of humans, skin contains millions of microorganisms. The largest and diverse microbiome is observed in gut region. Microbiome influences human health by modulating the innate and adaptive immune responses. There is a close connection between human microbiome with health and disease. Microbiome maintains an equilibrium state with the human body through the host–microbial symbiotic associations. The role of microbiome shaping the host immune functions and development is well explored. The balance of host system and microbiome may get altered by external or environmental stimuli like exposure to antibiotics. The frequent imbalance of microbiota is called as dysbiosis leading to pathological conditions. Dysbiosis associated with antibiotic treatment reduces the occurrence and number of commensals from body leading to the invasion of pathogens by breaking the colonization resistance. The restoration of microbiome is necessary to reduce the infections. Bacterial chemical signalling or quorum sensing plays important role in shaping the balance of microbiome, thereby reducing the pathogenic interactions.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Adler JL, Anderson RL, Boring JR, Nahmias AJ (1970) A protracted hospital-associated outbreak of salmonellosis due to a multiple-antibiotic-resistant strain of Salmonella indiana. J Pediatr 77:970–975. https://doi.org/10.1016/S0022-3476(70)80079-8
Alharthi A, Alhazmi S, Alburae N, Bahieldin A (2022) The human gut microbiome as a potential factor in autism spectrum disorder. Int J Mol Sci 23:1363. https://doi.org/10.3390/ijms23031363
Arrieta M-C, Stiemsma LT, Amenyogbe N et al (2014) The intestinal microbiome in early life: health and disease. Front Immunol 5:427. https://doi.org/10.3389/fimmu.2014.00427
Arvonen M, Virta LJ, Pokka T et al (2015) Repeated exposure to antibiotics in infancy: a predisposing factor for juvenile idiopathic arthritis or a sign of this group’s greater susceptibility to infections? J Rheumatol 42:521–526. https://doi.org/10.3899/jrheum.140348
Barko PC, McMichael MA, Swanson KS, Williams DA (2018) The gastrointestinal microbiome: a review. J Vet Intern Med 32:9–25. https://doi.org/10.1111/jvim.14875
Belizário JE, Napolitano M (2015) Human microbiomes and their roles in dysbiosis, common diseases, and novel therapeutic approaches. Front Microbiol 6:1050. https://doi.org/10.3389/fmicb.2015.01050
Belkaid Y, Harrison OJ (2017) Homeostatic immunity and the microbiota. Immunity 46:562–576. https://doi.org/10.1016/j.immuni.2017.04.008
Bergstrom KSB, Kissoon-Singh V, Gibson DL et al (2010) Muc2 protects against lethal infectious colitis by disassociating pathogenic and commensal bacteria from the colonic mucosa. PLoS Pathog 6(5):e1000902. https://doi.org/10.1371/journal.ppat.1000902
Bohnhoff M, Miller CP, Martin WR (1964) Resistance of the mouse’s intestinal tract to experimental salmonella infection. I. Factors which interfere with the initiation of infection by oral inoculation. J Exp Med 120:805–816. https://doi.org/10.1084/Jem.120.5.805
Bresalier RS, Chapkin RS (2020) Human microbiome in health and disease: the good, the bad, and the bugly. Dig Dis Sci 65:671–673. https://doi.org/10.1007/s10620-020-06059-y
Byrd AL, Belkaid Y, Segre JA (2018) The human skin microbiome. Nat Rev Microbiol 16:143–155. https://doi.org/10.1038/nrmicro.2017.157
Caballero-Flores G, Sakamoto K, Zeng MY et al (2019) Maternal immunization confers protection to the offspring against an attaching and effacing pathogen through delivery of IgG in breast milk. Cell Host Microbe 25:313–323.e4. https://doi.org/10.1016/j.chom.2018.12.015
Chen F, Stappenbeck TS (2019) Microbiome control of innate reactivity. Curr Opin Immunol 56:107–113. https://doi.org/10.1016/j.coi.2018.12.003
Chen X, Katchar K, Goldsmith JD et al (2008) A mouse model of Clostridium difficile-associated disease. Gastroenterology 135:1984–1992. https://doi.org/10.1053/j.gastro.2008.09.002
Chen YE, Fischbach MA, Belkaid Y (2018) Skin microbiota-host interactions. Nature 553:427–436. https://doi.org/10.1038/nature25177
Chen X, Lu Y, Chen T, Li R (2021) The female vaginal microbiome in health and bacterial vaginosis. Front Cell Infect Microbiol 11:1–15. https://doi.org/10.3389/fcimb.2021.631972
Chun E, Lavoie S, Fonseca-Pereira D et al (2019) Metabolite-sensing receptor Ffar2 regulates colonic group 3 innate lymphoid cells and gut immunity. Immunity 51:871–884.e6. https://doi.org/10.1016/j.immuni.2019.09.014
Corthier G, Muller MC, Elmer GW et al (1989) Interrelationships between digestive proteolytic activities and production and quantitation of toxins in pseudomembranous colitis induced by Clostridium difficile in gnotobiotic mice. Infect Immun 57:3922–3927. https://doi.org/10.1128/iai.57.12.3922-3927.1989
De La Cochetière MF, Durand T, Lepage P et al (2005) Resilience of the dominant human fecal microbiota upon short-course antibiotic challenge. J Clin Microbiol 43:5588–5592. https://doi.org/10.1128/JCM.43.11.5588-5592.2005
Deo PN, Deshmukh R (2019) Oral microbiome: unveiling the fundamentals. J Oral Maxillofac Pathol 23:122–128. https://doi.org/10.4103/jomfp.JOMFP_304_18
Di Caprio JM, Rantz LA (1950) Effects of terramycin on the bacterial flora of the bowel in man. Arch Intern Med 86:649–657. https://doi.org/10.1001/archinte.1950.00230170002001
Dickson RP, Erb-Downward JR, Martinez FJ, Huffnagle GB (2016) The microbiome and the respiratory tract. Annu Rev Physiol 78:481–504. https://doi.org/10.1146/annurev-physiol-021115-105238
Dominguez-Bello MG, Costello EK, Contreras M et al (2010) Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci 107:11971–11975. https://doi.org/10.1073/pnas.1002601107
Douce G, Goulding D (2010) Refinement of the hamster model of Clostridium difficile disease. Methods Mol Biol 646:215–227. https://doi.org/10.1007/978-1-60327-365-7_14
Dupont HL, Jiang ZD, Dupont AW, Utay NS (2020) The intestinal microbiome in human health and disease. Trans Am Clin Climatol Assoc 131:178–197
Fernández L, Pannaraj PS, Rautava S, RodrÃguez JM (2020) The microbiota of the human mammary ecosystem. Front Cell Infect Microbiol 10:586667. https://doi.org/10.3389/fcimb.2020.586667
Fukata M, Arditi M (2013) The role of pattern recognition receptors in intestinal inflammation. Mucosal Immunol 6:451–463. https://doi.org/10.1038/mi.2013.13
Gérard P (2014) Metabolism of cholesterol and bile acids by the gut microbiota. Pathogens 3:14–24. https://doi.org/10.3390/pathogens3010014
Gordon JI, Dewey KG, Mills DA, Medzhitov RM (2012) The human gut microbiota and undernutrition. Sci Transl Med 4:137ps12. https://doi.org/10.1126/scitranslmed.3004347
Greenbaum S, Greenbaum G, Moran-Gilad J, Weintraub AY (2019) Ecological dynamics of the vaginal microbiome in relation to health and disease. Am J Obstet Gynecol 220:324–335. https://doi.org/10.1016/j.ajog.2018.11.1089
Grice EA, Segre JA (2011) The skin microbiome. Nat Rev Microbiol 9:244–253. https://doi.org/10.1038/nrmicro2537
Harris VC, Haak BW, Boele van Hensbroek M, Wiersinga WJ (2017) The intestinal microbiome in infectious diseases: the clinical relevance of a rapidly emerging field. Open Forum Infect Dis 4:ofx144. https://doi.org/10.1093/ofid/ofx144
Hayes W, Sahu S (2020) The human microbiome: history and future. J Pharm Pharm Sci 23:404–411. https://doi.org/10.18433/jpps31525
Hooper LV, Littman DR, Macpherson AJ (2012) Interactions between the microbiota and the immune system. Science 336:1268–1273. https://doi.org/10.1126/science.1223490
Horton DB, Scott FI, Haynes K et al (2015) Antibiotic exposure and juvenile idiopathic arthritis: a case–control study. Pediatrics 136:e333–e343. https://doi.org/10.1542/peds.2015-0036
Iacob S, Iacob DG, Luminos LM (2019) Intestinal microbiota as a host defense mechanism to infectious threats. Front Microbiol 9:3328. https://doi.org/10.3389/fmicb.2018.03328
Jahoor A, Patel R, Bryan A et al (2008) Peroxisome proliferator-activated receptors mediate host cell proinflammatory responses to Pseudomonas aeruginosa autoinducer. J Bacteriol 190:4408–4415. https://doi.org/10.1128/JB.01444-07
Jakobsson HE, Jernberg C, Andersson AF et al (2010) Short-term antibiotic treatment has differing long-term impacts on the human throat and gut microbiome. PloS One 5:e9836. https://doi.org/10.1371/journal.pone.0009836
Jernberg C, Löfmark S, Edlund C, Jansson JK (2007) Long-term ecological impacts of antibiotic administration on the human intestinal microbiota. ISME J 1:56–66. https://doi.org/10.1038/ismej.2007.3
Johanesen P, Mackin K, Hutton M et al (2015) Disruption of the gut microbiome: Clostridium difficile infection and the threat of antibiotic resistance. Genes (Basel) 6:1347–1360. https://doi.org/10.3390/genes6041347
Kalia VC, Wood TK, Kumar P (2014) Evolution of resistance to quorum-sensing inhibitors. Microb Ecol 68:13–23. https://doi.org/10.1007/s00248-013-0316-y
Kastl AJ, Terry NA, Wu GD, Albenberg LG (2020) The structure and function of the human small intestinal microbiota: current understanding and future directions. Cell Mol Gastroenterol Hepatol 9:33–45. https://doi.org/10.1016/j.jcmgh.2019.07.006
Keeney KM, Yurist-Doutsch S, Arrieta MC, Finlay BB (2014) Effects of antibiotics on human microbiota and subsequent disease. Annu Rev Microbiol 68:217–235. https://doi.org/10.1146/annurev-micro-091313-103456
Kho ZY, Lal SK (2018) The human gut microbiome—a potential controller of wellness and disease. Front Microbiol 9:1–23. https://doi.org/10.3389/fmicb.2018.01835
Kirk MD, Pires SM, Black RE et al (2015) World Health Organization estimates of the global and regional disease burden of 22 foodborne bacterial, protozoal, and viral diseases, 2010: a data synthesis. PLoS Med 12:e1001940. https://doi.org/10.1371/journal.pmed.1001921
Kravchenko VV, Kaufmann GF, Mathison JC et al (2008) Modulation of gene expression via disruption of NF-κB signaling by a bacterial small molecule. Science 321:259–263. https://doi.org/10.1126/science.1156499
Kubinak JL, Petersen C, Stephens WZ et al (2015) MyD88 signaling in T cells directs IgA-mediated control of the microbiota to promote health. Cell Host Microbe 17:153–163. https://doi.org/10.1016/j.chom.2014.12.009
Kumar P, Koul S, Patel SKS et al (2015) Heterologous expression of quorum sensing inhibitory genes in diverse organisms. In: Kalia VC (ed) Quorum sensing vs quorum quenching: a battle with no end in sight. Springer, New Delhi, pp 343–356
Kumar P, Lee JH, Beyenal H et al (2020) Fatty acids as antibiofilm and antivirulence agents. Trends Microbiol 28:753–768. https://doi.org/10.1016/j.tim.2020.03.014
Kumar P, Lee J, Lee J (2021) Diverse roles of microbial indole compounds in eukaryotic systems. Biol Rev 96:2522–2545. https://doi.org/10.1111/brv.12765
Kuperman AA, Zimmerman A, Hamadia S et al (2020) Deep microbial analysis of multiple placentas shows no evidence for a placental microbiome. BJOG 127:159–169. https://doi.org/10.1111/1471-0528.15896
Kurkjian HM, Akbari MJ, Momeni B (2021) The impact of interactions on invasion and colonization resistance in microbial communities. PLoS Comput Biol 17:e1008643. https://doi.org/10.1371/journal.pcbi.1008643
Lazar V, Ditu LM, Pircalabioru GG et al (2018) Aspects of gut microbiota and immune system interactions in infectious diseases, immunopathology, and cancer. Front Immunol 9:1830. https://doi.org/10.3389/fimmu.2018.01830
Lepage P, Hösler R, Spehlmann ME et al (2011) Twin study indicates loss of interaction between microbiota and mucosa of patients with ulcerative colitis. Gastroenterology 141:227–236. https://doi.org/10.1053/j.gastro.2011.04.011
Li M, Wang B, Zhang M et al (2008) Symbiotic gut microbes modulate human metabolic phenotypes. Proc Natl Acad Sci U S A 105:2117–2122. https://doi.org/10.1073/pnas.0712038105
Li H, He J, Jia W (2016) The influence of gut microbiota on drug metabolism and toxicity. Expert Opin Drug Metab Toxicol 12:31–40. https://doi.org/10.1517/17425255.2016.1121234
Libertucci J, Young VB (2019) The role of the microbiota in infectious diseases. Nat Microbiol 16(3):107–114. https://doi.org/10.1016/j.tim.2007.12.008
Lim Y, Totsika M, Morrison M, Punyadeera C (2017) Oral microbiome: a new biomarker reservoir for oral and oropharyngeal cancers. Theranostics 7:4313–4321. https://doi.org/10.7150/thno.21804
Lu M, Xuan S, Wang Z (2019) Oral microbiota: a new view of body health. Food Sci Human Wellness 8:8–15. https://doi.org/10.1016/j.fshw.2018.12.001
Makki K, Deehan EC, Walter J, Bäckhed F (2018) The impact of dietary fiber on gut microbiota in host health and disease. Cell Host Microbe 23:705–715. https://doi.org/10.1016/j.chom.2018.05.012
Malys MK, Campbell L, Malys N (2015) Symbiotic and antibiotic interactions between gut commensal microbiota and host immune system. Medicina (Kaunas) 51:69–75. https://doi.org/10.1016/j.medici.2015.03.001
Manichanh C, Rigottier-Gois L, Bonnaud E et al (2006) Reduced diversity of faecal microbiota in Crohn’s disease revealed by a metagenomic approach. Gut 55:205–211. https://doi.org/10.1136/gut.2005.073817
Mazmanian SK, Cui HL, Tzianabos AO, Kasper DL (2005) An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 122:107–118. https://doi.org/10.1016/j.cell.2005.05.007
McGuckin MA, Lindén SK, Sutton P, Florin TH (2011) Mucin dynamics and enteric pathogens. Nat Rev Microbiol 9:265–278. https://doi.org/10.1038/nrmicro2538
Mohajeri MH, Brummer RJM, Rastall RA et al (2018) The role of the microbiome for human health: from basic science to clinical applications. Eur J Nutr 57:1–14. https://doi.org/10.1007/s00394-018-1703-4
Morgan XC, Huttenhower C (2012) Chapter 12: human microbiome analysis. PLoS Comput Biol 8:e1002808. https://doi.org/10.1371/journal.pcbi.1002808
Nuriel-Ohayon M, Neuman H, Koren O (2016) Microbial changes during pregnancy, birth, and infancy. Front Microbiol 7:1031. https://doi.org/10.3389/fmicb.2016.01031
Nyberg SD, Österblad M, Hakanen AJ et al (2007) Long-term antimicrobial resistance in Escherichia coli from human intestinal microbiota after administration of clindamycin. Scand J Infect Dis 39:514–520. https://doi.org/10.1080/00365540701199790
Ogunrinola GA, Oyewale JO, Oshamika OO, Olasehinde GI (2020) The human microbiome and its impacts on health. Int J Microbiol 2020:8045646. https://doi.org/10.1155/2020/8045646
Pan Y, Zhang X (2022) Diet and gut microbiome in fatty liver and its associated liver cancer. J Gastroenterol Hepatol 37:7–14. https://doi.org/10.1111/jgh.15713
Parfrey LW, Knight R (2012) Spatial and temporal variability of the human microbiota. Clin Microbiol Infect 18:5–7. https://doi.org/10.1111/j.1469-0691.2012.03861.x
Pascal M, Perez-Gordo M, Caballero T et al (2018) Microbiome and allergic diseases. Front Immunol 9:1584. https://doi.org/10.3389/fimmu.2018.01584
Pelzer E, Gomez-Arango LF, Barrett HL, Nitert MD (2017) Review: maternal health and the placental microbiome. Placenta 54:30–37. https://doi.org/10.1016/j.placenta.2016.12.003
Pena RT, Blasco L, Ambroa A et al (2019) Relationship between quorum sensing and secretion systems. Front Microbiol 10:1100. https://doi.org/10.3389/fmicb.2019.01100
Pflughoeft KJ, Versalovic J (2012) Human microbiome in health and disease. Annu Rev Pathol 7:99–122. https://doi.org/10.1146/annurev-pathol-011811-132421
Porras AM, Shi Q, Zhou H et al (2021) Geographic differences in gut microbiota composition impact susceptibility to enteric infection. Cell Rep 36:109457. https://doi.org/10.1016/j.celrep.2021.109457
Puel A, Döffinger R, Natividad A et al (2010) Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I. J Exp Med 207:291–297. https://doi.org/10.1084/jem.20091983
Qin J, Li R, Raes J et al (2010) A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464:59–65. https://doi.org/10.1038/nature08821
Rolhion N, Chassaing B (2016) When pathogenic bacteria meet the intestinal microbiota. Philos Trans R Soc Lond Ser B Biol Sci 371:20150504. https://doi.org/10.1098/rstb.2015.0504
Santacroce L, Charitos IA, Ballini A et al (2020) The human respiratory system and its microbiome at a glimpse. Biology (Basel) 9:318. https://doi.org/10.3390/biology9100318
Saraf VS, Sheikh SA, Ahmad A et al (2021) Vaginal microbiome: normalcy vs dysbiosis. Arch Microbiol 203:3793–3802. https://doi.org/10.1007/s00203-021-02414-3
Satokari R, Grönroos T, Laitinen K et al (2009) Bifidobacterium and lactobacillus DNA in the human placenta. Lett Appl Microbiol 48:8–12. https://doi.org/10.1111/j.1472-765X.2008.02475.x
Schnupf P, Gaboriau-Routhiau V, Cerf-Bensussan N (2018) Modulation of the gut microbiota to improve innate resistance. Curr Opin Immunol 54:137–144. https://doi.org/10.1016/j.coi.2018.08.003
Senn V, Bassler D, Choudhury R et al (2020) Microbial colonization from the fetus to early childhood–a comprehensive review. Front Cell Infect Microbiol 10:573735. https://doi.org/10.3389/fcimb.2020.573735
Seyhan AA, Carini C (2019) Are innovation and new technologies in precision medicine paving a new era in patients centric care? J Transl Med 17:114. https://doi.org/10.1186/s12967-019-1864-9
Sjölund M, Tano E, Blaser MJ et al (2005) Persistence of resistant Staphylococcus epidermidis after single course of clarithromycin. Emerg Infect Dis 11:1389–1393. https://doi.org/10.3201/eid1109.050124
Smeekens SP, Huttenhower C, Riza A et al (2014) Skin microbiome imbalance in patients with STAT1/STAT3 defects impairs innate host defense responses. J Innate Immun 6:253–262. https://doi.org/10.1159/000351912
Stecher B, Chaffron S, Käppeli R et al (2010) Like will to like: abundances of closely related species can predict susceptibility to intestinal colonization by pathogenic and commensal bacteria. PLoS Pathog 6:e1000711. https://doi.org/10.1371/journal.ppat.1000711
Sullivan A (2001) Effect of antimicrobial agents on the ecological balance of human microflora. Lancet Infect Dis 1:101–114. https://doi.org/10.1016/S1473-3099(01)00066-4
Thomas S, Izard J, Walsh E et al (2017) The host microbiome regulates and maintains human health: a primer and perspective for non-microbiologists. Cancer Res 77:1783–1812. https://doi.org/10.1158/0008-5472.CAN-16-2929
Thompson JA, Oliveira RA, Djukovic A et al (2015) Manipulation of the quorum sensing signal AI-2 affects the antibiotic-treated gut microbiota. Cell Rep 10:1861–1871. https://doi.org/10.1016/j.celrep.2015.02.049
Tshikantwa TS, Ullah MW, He F, Yang G (2018) Current trends and potential applications of microbial interactions for human welfare. Front Microbiol 9:1156. https://doi.org/10.3389/fmicb.2018.01156
Tuddenham S, Sears CL (2015) The intestinal microbiome and health. Curr Opin Infect Dis 28:464–470. https://doi.org/10.1097/QCO.0000000000000196
Vaishnava S, Yamamoto M, Severson KM, Ruhn KA, Yu X, Koren O, Ley R, Wakeland EK, Hooper LV (2011) The antibacterial lectin RegIIIgamma promotes the spatial segregation of microbiota and host in the intestine. Science 334:255–258. https://doi.org/10.1126/science.1209791
Vandamme D, Landuyt B, Luyten W, Schoofs L (2012) A comprehensive summary of LL-37, the factotum human cathelicidin peptide. Cell Immunol 280:22–35. https://doi.org/10.1016/j.cellimm.2012.11.009
Verma D, Garg PK, Dubey AK (2018) Insights into the human oral microbiome. Arch Microbiol 200:525–540. https://doi.org/10.1007/s00203-018-1505-3
Verwoerd A, Ter Haar NM, de Roock S et al (2016) The human microbiome and juvenile idiopathic arthritis. Pediatr Rheumatol 14:55. https://doi.org/10.1186/s12969-016-0114-4
Wampach L, Heintz-Buschart A, Hogan A et al (2017) Colonization and succession within the human gut microbiome by archaea, bacteria, and microeukaryotes during the first year of life. Front Microbiol 8:738. https://doi.org/10.3389/fmicb.2017.00738
Wang B, Yao M, Lv L et al (2017) The human microbiota in health and disease. Engineering 3:71–82. https://doi.org/10.1016/J.ENG.2017.01.008
Wang Y, Wang X, Zhu M et al (2022) The interplay between cervicovaginal microbial dysbiosis and cervicovaginal immunity. Front Immunol 13:1–11. https://doi.org/10.3389/fimmu.2022.857299
Waters CM, Bassler BL (2005) Quorum sensing: cell-to-cell communication in bacteria. Annu Rev Cell Dev Biol 21:319–346. https://doi.org/10.1146/annurev.cellbio.21.012704.131001
Whiteside SA, Razvi H, Dave S et al (2015) The microbiome of the urinary tract—a role beyond infection. Nat Rev Urol 12:81–90. https://doi.org/10.1038/nrurol.2014.361
Wiertsema SP, van Bergenhenegouwen J, Garssen J, Knippels LMJ (2021) The interplay between the gut microbiome and the immune system in the context of infectious diseases throughout life and the role of nutrition in optimizing treatment strategies. Nutrients 13:886. https://doi.org/10.3390/nu13030886
Wlodarska M, Willing B, Keeney KM et al (2011) Antibiotic treatment alters the colonic mucus layer and predisposes the host to exacerbated Citrobacter rodentium-induced colitis. Infect Immun 79:1536–1545. https://doi.org/10.1128/IAI.01104-10
Wu L, Luo Y (2021) Bacterial quorum-sensing systems and their role in intestinal bacteria-host crosstalk. Front Microbiol 12:611413. https://doi.org/10.3389/fmicb.2021.611413
Wu H-J, Wu E (2012) The role of gut microbiota in immune homeostasis and autoimmunity. Gut Microbes 3:4–14. https://doi.org/10.4161/gmic.19320
Xu L, Surathu A, Raplee I et al (2020) The effect of antibiotics on the gut microbiome: a metagenomics analysis of microbial shift and gut antibiotic resistance in antibiotic treated mice. BMC Genomics 21:263. https://doi.org/10.1186/s12864-020-6665-2
Xue J, Chi L, Tu P et al (2021) Detection of gut microbiota and pathogen produced N-acyl homoserine in host circulation and tissues. NPJ Biofilms Microbiomes 7:53. https://doi.org/10.1038/s41522-021-00224-5
Yang L, Bajinka O, Jarju PO et al (2021) The varying effects of antibiotics on gut microbiota. AMB Express 11:116. https://doi.org/10.1186/s13568-021-01274-w
York A (2019) Microbiota succession in early life. Nat Rev Microbiol:s8–s9. https://www.nature.com/articles/d42859-019-00010-6.
Yoshii K, Hosomi K, Sawane K, Kunisawa J (2019) Metabolism of dietary and microbial Vitamin B family in the regulation of host immunity. Front Nutr 6:48. https://doi.org/10.3389/fnut.2019.00048
Young VB (2017) The role of the microbiome in human health and disease: an introduction for clinicians. BMJ 356:j831. https://doi.org/10.1136/bmj.j831
Young VB, Schmidt TM (2004) Antibiotic-associated diarrhea accompanied by large-scale alterations in the composition of the fecal microbiota. J Clin Microbiol 42:1203–1206. https://doi.org/10.1128/JCM.42.3.1203-1206.2004
Zakis DR, Paulissen E, Kornete L et al (2022) The evidence for placental microbiome and its composition in healthy pregnancies: a systematic review. J Reprod Immunol 149:103455. https://doi.org/10.1016/j.jri.2021.103455
Zhang X, Coker OO, Chu ESH et al (2021) Dietary cholesterol drives fatty liver-associated liver cancer by modulating gut microbiota and metabolites. Gut 70:761–774. https://doi.org/10.1136/gutjnl-2019-319664
Zheng D, Liwinski T, Elinav E (2020) Interaction between microbiota and immunity in health and disease. Cell Res 30:492–506. https://doi.org/10.1038/s41422-020-0332-7
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Anju, V.T., Busi, S., Mohan, M.S., Dyavaiah, M. (2023). Human Microbiome and the Susceptibility to Infections. In: Kothari, V., Kumar, P., Ray, S. (eds) Probiotics, Prebiotics, Synbiotics, and Postbiotics. Springer, Singapore. https://doi.org/10.1007/978-981-99-1463-0_7
Download citation
DOI: https://doi.org/10.1007/978-981-99-1463-0_7
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-99-1462-3
Online ISBN: 978-981-99-1463-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)